ProQR Therapeutics N.V.

Filed a patent for "antisense oligonucleotides for the treatment of neurological disorders" on Fri, March 24, 2023

Filed a patent for "antisense oligonucleotides for rna editing" on Thu, October 12, 2023

Filed a patent for "single-stranded rna-editing oligonucleotides" on Thu, September 7, 2023

Filed a patent for "antisense oligonucleotides for use in the treatment of corneal dystrophies" on Thu, May 2, 2024

Filed a patent for "antisense oligonucleotides for nucleotide deamination in the treatment of stargardt disease" on Thu, February 9, 2023

Filed a patent for "antisense oligonucleotides for use in the treatment of usher syndrome" on Thu, May 4, 2023